Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Context/Objective: The objective of the study was to determine whether anti-Mullerian hormone (AMH) and inhibin B are viable endocrine biomarkers for framing the menopause transition from initiation to the final menstrual period (FMP). Design: We assayed AMH, inhibin B, and FSH in 300 archival follicular phase specimens from 50 women with six consecutive annual visits commencing in 1993 when all women were in the pre- and perimenopausal menopause stages. Subsequently each woman had a documented FMP. The assay results were fitted as individual-woman profiles and then related to time to FMP and age at FMP as outcomes. Results: Based on annual values from six time points prior to the FMP, logAMH longitudinal profiles declined and were highly associated with a time point 5 yr prior to FMP [including both observed and values below detection (P < 0.0001 and P = 0.0001, respectively)]. Baseline AMH profiles were also associated with age at FMP (P = 0.035). Models of declining loginhibin B profiles (including both observed and values below detection) were associated with time to FMP (P < 0.0001 and P = 0.0003, respectively). There was no significant association of loginhibin B profiles with age at FMP. Conclusions: AMH, an endocrine marker that reflects the transition of resting primordial follicles to growing follicles, declined to a time point 5 yr prior to the FMP; this may represent a critical biological juncture in the menopause transition. Low and nondetectable levels inhibin B levels also were observed 4–5 yr prior to the FMP but were less predictive of time to FMP or age at FMP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause
Faddy, M. J., Gosden, R. G., Gougeon, A., Richardson, S. J., & Nelson, J. F. (1992) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137570 · Cited by 1,365
The variability of female reproductive ageing
te Velde, E. R. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.2.141 · Cited by 1,214
Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1
Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (1999) · Endocrinology · doi:10.1210/endo.140.12.7204 · Cited by 1,011
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
van Rooij, I. A. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 951
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/en.142.11.4891 · Cited by 772
RICHARDSON, S. J., SENIKAS, V., & NELSON, J. F. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-6-1231 · Cited by 710
van Rooij, I. A. J., Broekmans, F. J. M., Scheffer, G. J., Looman, C. W. N., Habbema, J. D. F., de Jong, F. H., Fauser, B. J. C. M., Themmen, A. P. N., & te Velde, E. R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.029 · Cited by 582
Seifer, D. B., MacLaughlin, D. T., Christian, B. P., Feng, B., & Shelden, R. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03201-0 · Cited by 494
Faddy, M. J., & Gosden, R. G. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019422 · Cited by 422
Cited by
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., & de Villiers, T. J. (2012) · Menopause · doi:10.1097/gme.0b013e31824d8f40 · Cited by 1,705
Self-citationHarlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., de Villiers, T. J., & for the STRAW + 10 Collaborative Group (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3362 · Cited by 1,325
Self-citationOvarian aging: mechanisms and clinical consequences
Broekmans, F. J., Soules, M. R., & Fauser, B. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0006 · Cited by 1,248
“In addition, follow-up studies in femalevolunteershavedemonstrated that several ovarian reserve tests are predictive of early occurrence of the menopausal transition or menopause (65, 66).”
BackgroundDumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., de Villiers, T. J., & for the Straw +10 Collaborative Group (2012) · Climacteric · doi:10.3109/13697137.2011.650656 · Cited by 817
Self-citationCorrelation of ovarian reserve tests with histologically determined primordial follicle number
Hansen, K. R., Hodnett, G. M., Knowlton, N., & Craig, L. B. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.04.006 · Cited by 534
Davis, S. R., Lambrinoudaki, I., Lumsden, M., Mishra, G. D., Pal, L., Rees, M., Santoro, N., & Simoncini, T. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.4 · Cited by 502
Broer, S. L., van Disseldorp, J., Broeze, K. A., Dolleman, M., Opmeer, B. C., Bossuyt, P., Eijkemans, M. J. C., Mol, B.-W. J., Broekmans, F. J. M., on behalf of the IMPORT study group, et al. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms041 · Cited by 457
Randolph, J. F., Zheng, H., Sowers, M. R., Crandall, C., Crawford, S., Gold, E. B., & Vuga, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1746 · Cited by 369
Self-citationAnti-Müllerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women
Broer, S. L., Eijkemans, M. J. C., Scheffer, G. J., van Rooij, I. A. J., de Vet, A., Themmen, A. P. N., Laven, J. S. E., de Jong, F. H., te Velde, E. R., Fauser, B. C., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2776 · Cited by 338
Anti-Mullerian hormone (AMH): what do we still need to know?
La Marca, A., Broekmans, F. J., Volpe, A., Fauser, B. C., Macklon, N. S., & on behalf of the ESHRE Special Interest Group for Reproductive Endocrinology - AMH Round Table (2009) · Human Reproduction · doi:10.1093/humrep/dep210 · Cited by 327
Anti-Mullerian Hormone as a Predictor of Time to Menopause in Late Reproductive Age Women
Freeman, E. W., Sammel, M. D., Lin, H., & Gracia, C. R. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3032 · Cited by 277
Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency
Visser, J. A., Schipper, I., Laven, J. S. E., & Themmen, A. P. N. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.224 · Cited by 264
Iliodromiti, S., Anderson, R. A., & Nelson, S. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu062 · Cited by 260
RETIRED: Advanced Reproductive Age and Fertility
Liu, K., Case, A., Cheung, A. P., Sierra, S., AlAsiri, S., Carranza-Mamane, B., Case, A., Dwyer, C., Graham, J., Havelock, J., et al. (2011) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)35087-3 · Cited by 254
Metabolic Syndrome and Menopause
(2015) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2015.07.001 · Cited by 215
Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone
Lie Fong, S., Laven, J. S. E., Hakvoort-Cammel, F. G. A. J., Schipper, I., Visser, J. A., Themmen, A. P. N., de Jong, F. H., & van den Heuvel-Eibrink, M. M. (2008) · Human Reproduction · doi:10.1093/humrep/den487 · Cited by 190
“It was concluded that low or non-detectable AMH levels were predictive of menopausal transition, whereas serum inhibin B and FSH levels were less predictive (Sowers et al., 2008).”
BackgroundFemale reproduction and type 1 diabetes: From mechanisms to clinical findings
Codner, E., Merino, P. M., & Tena-Sempere, M. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms024 · Cited by 182
“during the transition to menopause, and serum inhibin B (Sowers et al., 2008).”
BackgroundSowers, M. R., Zheng, H., McConnell, D., Nan, B., Harlow, S. D., & Randolph, J. F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1056 · Cited by 135
Self-citationLunding, S. A., Aksglaede, L., Anderson, R. A., Main, K. M., Juul, A., Hagen, C. P., & Pedersen, A. T. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1621 · Cited by 125
“AMH was higher in TS patients with mosaicism (45,X/ 46,XX) compared with patients with 45,X (16 pmol/L [ 2–92] vs 2 pmol/L [ 2–2]; P .”
Background
Metadata
- Authors
- Sowers, M. F. R., Eyvazzadeh, A. D., McConnell, D., Yosef, M., Jannausch, M. L., Zhang, D., Harlow, S., & Randolph, J. F.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-09-01
- Volume
- 93
- Issue
- 9
- Pages
- 3478-3483
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2004532825
- Cited by
- 377
- References
- 34
- FWCI
- 30.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.